Table 2. Characteristics of BWHS subjects after exclusion of subjects taking metformin or non-steroidal anti-inflammatory medications.
| Lean, healthy | Obese, healthy | Obese, unhealthy, no metformin | P-value | |
|---|---|---|---|---|
| Group | I | II | III | |
| N | 25 | 22 | 15 | |
| Mean age, y (SD) | 51.28 (4.1) | 52.32 (4.86) | 52.47 (4.17) | >0.05 |
| WHR | 0.76 (0.04) | 0.80 (0.08) | 0.87 (0.07) | < 0.001 |
| Median BMI, kg/m2 (range) | 21.99 (20.10–23.94) | 34.21 (30.58–46.91) | 40.39 (30.92–47.66) | <0.001 |
| HbA1c, % (SD) | 5.7 (0.43) | 5.67 (0.32) | 8.38 (1.95) | <0.001 |
Abbreviations: BMI, Body Mass Index; HbA1c, glycated hemoglobin; WHR, waist to hip ratio.